This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wise, R Articles by Bedford, K A Search for Related Content PubMed PubMed Citation Articles by Wise, R Articles by Bedford, K A

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1979 September; 16(3): 341-345

LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics.

R Wise, J M Andrews and K A Bedford

ABSTRACT

The in vitro activities of LY127935 (LY) were compared with those of other beta-lactam antibiotics. LY was highly active (minimal inhibitory concentration [MIC] range 0.06 to 0.25 micrograms/ml) against the common Enterobacteriaceae (including Providencia stuartiia, Enterobacter, and Serrati marcescens), 8 to 16 times more active than cefoxitin, cefuroxime, or cefazolin, and from one-half to one-eighth as active as cefotaxime (HR756). The activity of LY against Pseudomonas aeruginosa (with MICs of 4 and 64 micrograms/ml for 50 and 90% of test strains, respectively) was essentially similar to that of cefotaxime, but was only one-half as active as CGP 7174/E. LY, cefoxitin, and cefotaxime were essentially equally active against Bacteroides fragilis--each was more active than cefuroxime and cefazolin. Against Staphylococcus aureus, LY (50% MIC and 90% MIC of 4 and 16 micrograms/ml, respectively) was less active than cefotaxime, cefoxitin, or cefuroxime and one-eighth as active as cefazolin. The composition and pH of the culture medium had little effect on the activity of LY, although 7.2 appeared to be the optimum pH.

---

Antimicrob Agents Chemother. 1979 September; 16(3): 341-345

This article has been cited by other articles:

• Fett, D. R., Silverman, C. A., Yoshizumi, M. O. (1984). Moxalactam Retinal Toxicity. Arch Ophthalmol 102: 435-438 [Abstract]  
• Axelrod, J. L., Kochman, R. S. (1982). Moxalactam Concentration in Human Aqueous Humor After Intravenous Administration. Arch Ophthalmol 100: 1334-1336 [Abstract]